Your browser doesn't support javascript.
loading
Solid-phase synthesis and bioactivity evaluation of cherimolacyclopeptide E.
Yoshida, Yuka; Inagaki, Minoru; Masuda, Yuichi.
Afiliação
  • Yoshida Y; Graduate School of Bioresources, Mie University, Tsu, Japan.
  • Inagaki M; Graduate School of Bioresources, Mie University, Tsu, Japan.
  • Masuda Y; Graduate School of Bioresources, Mie University, Tsu, Japan.
J Pept Sci ; 27(6): e3308, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33586251
ABSTRACT
Cherimolacylopeptide E (1) is a cyclic hexapeptide isolated from the seeds of Annona cherimola. Peptide 1 reportedly exhibits potent cytotoxicity against KB cells (IC50 0.017 µM). To confirm the structure and bioactivity of 1, we conducted a total synthesis of its proposed structure. The synthesis was accomplished via solid-phase peptide elongation and macrocyclization by employing Fmoc/OAll-protected amino acids on 2-Cl-trityl resin. NMR analysis revealed that synthetic 1 exists in two conformations in pyridine-d5 . As the spectroscopic data of the major conformer of synthetic 1 were consistent with those of natural 1, the structure of cherimolacyclopeptide E was confirmed to be 1. However, our synthetic 1 exhibited low cytotoxicity against KB cells (IC50 > 100 µM). In contrast to previously-reported findings, our synthetic 1 exhibited little antibacterial activity against Escherichia coli.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos Cíclicos / Annona / Técnicas de Síntese em Fase Sólida Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos Cíclicos / Annona / Técnicas de Síntese em Fase Sólida Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article